ASEPTIC EXCELLENCE PARTNER financials
A multi-period view of the public annual-account figures reported for ASEPTIC EXCELLENCE PARTNER, with comparable measures and links to available source documents.
Company overviewRegistry number
0630621447
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for ASEPTIC EXCELLENCE PARTNER
2025 versus 2024
- Operating line
- €160,178
- EBITDA
- €159,292
- Total assets
- €469,697
- Equity
- €146,598
+320.3%
+331.6%
+9.8%
-18%
EBITDA margin +99.4% · Equity ratio +31.2%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €160,178 | €159,292 | €469,697 | €146,598 | - |
| 202431 Dec 2024 | €38,108 | €36,910 | €427,800 | €178,821 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.